Onconova Therapeutics Highlights Data On Genomic Profiles Of Higher-Risk Myelodysplastic Syndromes Patients Refractory To Azacitidine Therapy Enrolled In INSPIRE Trial, Updated Oral Rigosertib Data At ASH